133 related articles for article (PubMed ID: 38788043)
1. A meta-analysis of recombinant human endostatin combined with NP regimen for treating non-small cell lung cancer.
Gao C; Gao C; Yuan Q
Medicine (Baltimore); 2024 May; 103(21):e38027. PubMed ID: 38788043
[TBL] [Abstract][Full Text] [Related]
2. Endostar (rh-endostatin) versus placebo in combination with vinorelbine plus cisplatin chemotherapy regimen in treatment of advanced non-small cell lung cancer: A meta-analysis.
An J; Lv W
Thorac Cancer; 2018 May; 9(5):606-612. PubMed ID: 29575575
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of rh-endostatin combined with chemotherapy versus chemotherapy alone for advanced NSCLC: a meta-analysis review].
Cao D; Ge W; Wang H; Zhang L; Zheng Y; Zhang J
Zhongguo Fei Ai Za Zhi; 2011 May; 14(5):404-13. PubMed ID: 21569645
[TBL] [Abstract][Full Text] [Related]
4. Endostar combined with chemotherapy versus chemotherapy alone for advanced NSCLCs: a meta-analysis.
Ge W; Cao DD; Wang HM; Jie FF; Zheng YF; Chen Y
Asian Pac J Cancer Prev; 2011; 12(10):2705-11. PubMed ID: 22320978
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of aidi injection combination with vinorelbine and cisplatin for advanced non-small-cell lung carcinoma: A systematic review and meta-analysis of 54 randomized controlled trials.
Xiao Z; Jiang Y; Wang CQ; Hu SS; Huang XR; Chen XF; Huang J; Shan LJ; Tang YH; Wang YH; Gong QH; Feng JH; Xiao X; Li XF
Pharmacol Res; 2020 Mar; 153():104637. PubMed ID: 31935454
[TBL] [Abstract][Full Text] [Related]
6. Endostar combined with chemotherapy versus chemotherapy alone for advanced NSCLCs: a meta-analysis.
Ge W; Cao DD; Wang HM; Jie FF; Zheng YF; Chen Y
Asian Pac J Cancer Prev; 2011; 12(11):2901-7. PubMed ID: 22393961
[TBL] [Abstract][Full Text] [Related]
7. A network meta-analysis: The best Yiqi Fuzheng Chinese herbal injections for use based on the NP regimen to treat NSCLC.
Luo H; Zheng W; Yan Q; Wang B; Ye B; Deng S; He F; Yang X; Wang X
Medicine (Baltimore); 2020 Jul; 99(31):e20500. PubMed ID: 32756075
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.
Vasconcellos VF; Marta GN; da Silva EM; Gois AF; de Castria TB; Riera R
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD009256. PubMed ID: 31930743
[TBL] [Abstract][Full Text] [Related]
9. Systematic Evaluation Meta-Analysis of the Efficacy of Recombinant Human Endostatin Combined with Gemcitabine and Cisplatin in Non-Small-Cell Lung Cancer.
Zhang L; He Y; Yi C; Huang M
J Healthc Eng; 2022; 2022():3208780. PubMed ID: 35340250
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of cinobufacini injection combined with vinorelbine and cisplatin regimen chemotherapy for stage III/IV non-small cell lung cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.
Li Q; Liang RL; Yu QR; Tian DQ; Zhao LN; Wang WW; Xiao H; Yong XJ; Peng XD
Medicine (Baltimore); 2020 Jul; 99(31):e21539. PubMed ID: 32756206
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of endostar combined with chemotherapy in multi-cycle treatment of patients with advanced non-small cell lung cancer].
Li N; Jin ZL; Liu ZJ; Wang J; Li K
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):937-42. PubMed ID: 22340106
[TBL] [Abstract][Full Text] [Related]
12. Endostar continuous versus intermittent intravenous infusion combined with chemotherapy for advanced NSCLC: a systematic review and meta-analysis including non-randomized studies.
Wang B; Xu L; Li Q; Man S; Jin C; Liu L; Zhan S; Ning Y
BMC Cancer; 2020 Oct; 20(1):1021. PubMed ID: 33087103
[TBL] [Abstract][Full Text] [Related]
13. [Vinorelbine plus oxaliplatin versus vinorelbine plus cisplatin for advanced non-small cell lung cancer: a systematic review].
Liu X; Ma L; Yang K; Tian J
Zhongguo Fei Ai Za Zhi; 2010 Feb; 13(2):112-7. PubMed ID: 20673502
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of endostar combined with cisplatin in treatment of non-small cell lung cancer with malignant pleural effusion: A meta-analysis.
Hu Y; Zhou Z; Luo M
Medicine (Baltimore); 2022 Dec; 101(52):e32207. PubMed ID: 36595983
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.
de Castria TB; da Silva EM; Gois AF; Riera R
Cochrane Database Syst Rev; 2013 Aug; (8):CD009256. PubMed ID: 23949842
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human endostatin combined with chemotherapy for advanced squamous cell lung cancer: a meta-analysis.
Feng L; Wang Z; Jing L; Zhou Z; Shi S; Deng R; Liu Y; Meng Q
World J Surg Oncol; 2021 Feb; 19(1):64. PubMed ID: 33637113
[TBL] [Abstract][Full Text] [Related]
17. [A meta-analysis of platinum plus docetaxel or vinorelbine in the first-line treatment of advanced non-small cell lung cancer].
Liu T; Wu H; Zhuang X; Lu D; Cai R; Wang W
Zhongguo Fei Ai Za Zhi; 2014 Apr; 17(4):327-35. PubMed ID: 24758908
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for advanced non-small cell lung cancer in the elderly population.
Santos FN; de Castria TB; Cruz MR; Riera R
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010463. PubMed ID: 26482542
[TBL] [Abstract][Full Text] [Related]
19. Assessment on the Efficacy and Safety of Aidi Injection Combined with Vinorelbine and Cisplatin for Treatment of Advanced Nonsmall Cell Lung Cancer.
Zhao HY; Zhou HY; Wang YT; Chen W; Qi SY; Cao JL; Li GH
Chin Med J (Engl); 2016 Mar; 129(6):723-30. PubMed ID: 26960377
[TBL] [Abstract][Full Text] [Related]
20. Real-world outcomes of various regimens of recombinant human endostatin combined with chemotherapy in non-driver gene mutation advanced non-small cell lung cancer.
Wang Z; Zhang H; Zhou C; Long X; Guan R; Yang N; Zhang Y
Cancer Med; 2019 Apr; 8(4):1434-1441. PubMed ID: 30762300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
